Loading provider…
Loading provider…
Hematology & Oncology Physician in Englewood, OH
NPI: 1023057148Primary Practice Location
UPPER VALLEY MEDICAL CENTER
3130 N County Road 25a, Troy, OH
Primary Employer
Dayton Physicians Radiation Oncology - 1111 Sweitzer
daytonphysicians.com
HQ Phone
Get MD Howard's Phone Numberphone_androidMobile
Get MD Howard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 115 | 241 |
| 2 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 59 | 125 |
| 3 | 96413Infusion of chemotherapy into a vein up to 1 hour | 53 | 196 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 50 | 132 |
| 5 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 45 | 199 |
Authors: Rita Sanghvi Mehta, Rakesh Gaur, Harry Bear, Eleftherios Mamounas, Louis Fehrenbacher, Norman Wolmark
Journal: Ann Surg Oncol
Publication Date: 2016-11-18
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
Authors: Rita Sanghvi Mehta, Rakesh Gaur, Harry Bear, Eleftherios Mamounas, Norman Wolmark, James Atkins
Publication Date: 2012-01-27
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Authors: John Zapas, David Biggs, Eleftherios Mamounas, Norman Wolmark, Catherine Azar, Jonathan Polikoff, James Atkins
Publication Date: 2012-09-19
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, PROCEDURE: Biospecimen Collection, DRUG: Gemcitabine Hydrochloride, DRUG: Paclitaxel, DRUG: Eribulin Mesylate, PROCEDURE: Computed Tomography, PROCEDURE: Bone Scan, BIOLOGICAL: Sacituzumab Govitecan
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Atezolizumab, PROCEDURE: Computed Tomography, RADIATION: Hypofractionated Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, PROCEDURE: Computed Tomography, DRUG: Doxorubicin Hydrochloride, PROCEDURE: Lumbar Puncture